Alexandria, Va. (March 15, 2022) — The National Home Infusion Foundation (NHIF) is proud to announce that the recipient of the 2022 Outstanding Abstract Achievement Award (OAAA) is Cheyenne D. Johnson, PharmD from Option Care Health.
The OAAA is awarded to an individual that presents a poster during the National Home Infusion Association’s (NHIA) Annual Conference on a relevant home and specialty infusion topic. These posters examine an innovative approach to clinical practice, identify an opportunity or best practice, or demonstrate quality improvement within the home and specialty infusion industry.
The program offers an opportunity for home and specialty infusion professionals to receive peer-reviewed feedback and share their project findings. Five finalists for the award shared their posters during a live session at NHIA’s 2022 Annual Conference on March 14.
Johnson, a pharmacy resident at Option Care Health in Lincoln, Nebraska, received the award for her poster titled, “An Investigation on Empiric Vancomycin Dose Reduction in Home Infusion Patients to Optimize Patient Safety.” Her poster examined whether empirically reducing vancomycin correlates with decreased incidence of acute kidney injury as patients transition from acute care to home infusion therapy. As the winner, Johnson will receive a $1,000 scholarship, an opportunity to develop her findings into a manuscript for publication.
“Congratulations to Johnson and all those who competed for this prestigious award; their commitment to advancing home and specialty infusion clinical practice through research and patient case presentation is commendable. It is exciting to see the innovative topics and findings presented through this program this year, and how this research contributes to advancing the home and specialty infusion profession,” said NHIF Board Chair David Franklin, MSA.
NHIF would also like to acknowledge this year’s Honorable Mention, Jake Burkhalter, PharmD, a pharmacy resident at Chartwell, PA, for his poster titled, “Utility of Olive Oil Based Lipid Emulsion as an Alternative Fatty Acid Source in Parenteral Nutrition Patients.”
Last week concluded the 2024 National Home Infusion Association Annual Conference (NHIA 2024), which brings together more than 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits.
The National Home Infusion Association has announced the finalists for its 2024 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
CMS released its annual monitoring report[link] on the Medicare Part B Home Infusion Therapy (HIT) Services benefit showing that both provider participation and beneficiary utilization have declined over the past year.
